United States · FDA National Drug Code directory
Sulfasalazine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 59762-0104_0e53b1e5-3efe-4e5a-8d20-108f96490393
- Product NDC
- 59762-0104
- Form
- TABLET, DELAYED RELEASE
- Composition / generic term
- Sulfasalazine
- Labeler
- Mylan Pharmaceuticals Inc.
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start / end (source format)
- 20050505
- Source listing expiry
- 20271231
Source-listed ingredients
- SULFASALAZINE — 500 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (59762-0104-5) / 100 TABLET, DELAYED RELEASE in 1 BOTTLE · 59762-0104-5
- 1 BOTTLE in 1 CARTON (59762-0104-6) / 300 TABLET, DELAYED RELEASE in 1 BOTTLE · 59762-0104-6
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →